Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 20/20 | 1.00 |
| ▸ | PPARA | Q07869 | 19/20 | 1.00 |
| ▸ | PPARD | Q03181 | 7/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14841186 | 0.93 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL20235377 | 0.93 | PPARG (0.87) | PPARGPPARAPPARD | |
| SCHEMBL14848995 | 0.91 | PPARG (0.84) | PPARGPPARAPPARD | |
| SCHEMBL14848993 | 0.91 | PPARG (0.82) | PPARGPPARAPPARD | |
| SCHEMBL14849086 | 0.91 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL20232431 | 0.90 | PPARG (0.82) | PPARGPPARAPPARD | |
| SCHEMBL14851137 | 0.90 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL14851133 | 0.90 | PPARG (0.81) | PPARGPPARAPPARD | |
| SCHEMBL14849073 | 0.89 | PPARG (0.80) | PPARGPPARAPPARD | |
| SCHEMBL4895550 | 0.89 | PPARG (0.79) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018102399-A1 | METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES | T3D THERAPEUTICS, INC. (US) | 2018-06-07 | — | — | WO | disclosed |
| US-9346770-B2 | Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2016-05-24 | — | — | US | disclosed |
| US-9346770-B2 | Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2016-05-24 | — | — | US | disclosed |
| US-20130089613-A1 | Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2013-04-11 | — | — | US | disclosed |
| US-20130089613-A1 | Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2013-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130089613-A1 | Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses | PPARA, PPARG, PPARD | PPARG 2/4885PPARA 1/4885PPARD 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.